vs

Side-by-side financial comparison of NEXTNAV INC. (NN) and Arcadia Biosciences, Inc. (RKDA). Click either name above to swap in a different company.

NEXTNAV INC. is the larger business by last-quarter revenue ($945.0K vs $901.0K, roughly 1.0× Arcadia Biosciences, Inc.). Arcadia Biosciences, Inc. runs the higher net margin — -148.3% vs -7191.7%, a 7043.5% gap on every dollar of revenue. On growth, Arcadia Biosciences, Inc. posted the faster year-over-year revenue change (-25.8% vs -50.5%). Over the past eight quarters, Arcadia Biosciences, Inc.'s revenue compounded faster (-4.5% CAGR vs -5.0%).

NextNav Inc. is a specialized technology company focused on high-precision 3D geolocation and positioning solutions. Its services deliver accurate vertical location data for public safety operations, IoT use cases, mobile network management, and commercial location services, catering to enterprise and government clients across North America and select global markets.

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.

NN vs RKDA — Head-to-Head

Bigger by revenue
NN
NN
1.0× larger
NN
$945.0K
$901.0K
RKDA
Growing faster (revenue YoY)
RKDA
RKDA
+24.7% gap
RKDA
-25.8%
-50.5%
NN
Higher net margin
RKDA
RKDA
7043.5% more per $
RKDA
-148.3%
-7191.7%
NN
Faster 2-yr revenue CAGR
RKDA
RKDA
Annualised
RKDA
-4.5%
-5.0%
NN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NN
NN
RKDA
RKDA
Revenue
$945.0K
$901.0K
Net Profit
$-68.0M
$-1.3M
Gross Margin
21.4%
Operating Margin
-1706.1%
-152.8%
Net Margin
-7191.7%
-148.3%
Revenue YoY
-50.5%
-25.8%
Net Profit YoY
-110.6%
67.1%
EPS (diluted)
$-0.37
$-0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NN
NN
RKDA
RKDA
Q4 25
$945.0K
$901.0K
Q3 25
$887.0K
$1.3M
Q2 25
$1.2M
$1.5M
Q1 25
$1.5M
$1.2M
Q4 24
$1.9M
$1.2M
Q3 24
$1.6M
$1.5M
Q2 24
$1.1M
$1.3M
Q1 24
$1.0M
$987.0K
Net Profit
NN
NN
RKDA
RKDA
Q4 25
$-68.0M
$-1.3M
Q3 25
$483.0K
$856.0K
Q2 25
$-63.2M
$-4.5M
Q1 25
$-58.6M
$2.6M
Q4 24
$-32.3M
$-4.1M
Q3 24
$-13.6M
$-1.6M
Q2 24
$-24.4M
$1.1M
Q1 24
$-31.6M
$-2.4M
Gross Margin
NN
NN
RKDA
RKDA
Q4 25
21.4%
Q3 25
32.1%
Q2 25
43.4%
Q1 25
43.2%
Q4 24
31.9%
Q3 24
32.9%
Q2 24
51.5%
Q1 24
52.3%
Operating Margin
NN
NN
RKDA
RKDA
Q4 25
-1706.1%
-152.8%
Q3 25
-2239.6%
-88.5%
Q2 25
-1434.3%
-34.4%
Q1 25
-1104.9%
44.2%
Q4 24
-772.6%
-187.7%
Q3 24
-862.0%
-114.5%
Q2 24
-1387.5%
Q1 24
-1544.0%
-160.9%
Net Margin
NN
NN
RKDA
RKDA
Q4 25
-7191.7%
-148.3%
Q3 25
54.5%
65.7%
Q2 25
-5257.5%
-306.4%
Q1 25
-3806.3%
216.6%
Q4 24
-1688.6%
-334.5%
Q3 24
-846.9%
-104.9%
Q2 24
-2207.2%
81.2%
Q1 24
-3022.0%
-245.5%
EPS (diluted)
NN
NN
RKDA
RKDA
Q4 25
$-0.37
$-0.97
Q3 25
$-0.12
$0.62
Q2 25
$-0.48
$-3.26
Q1 25
$-0.45
$1.90
Q4 24
$-0.24
$-2.99
Q3 24
$-0.11
$-1.18
Q2 24
$-0.21
$0.78
Q1 24
$-0.28
$-1.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NN
NN
RKDA
RKDA
Cash + ST InvestmentsLiquidity on hand
$259.5M
$4.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-86.2M
$4.1M
Total Assets
$247.0M
$6.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NN
NN
RKDA
RKDA
Q4 25
$259.5M
$4.6M
Q3 25
$167.6M
$5.9M
Q2 25
$176.1M
$4.4M
Q1 25
$188.4M
$3.2M
Q4 24
$80.1M
$4.2M
Q3 24
$86.8M
$6.6M
Q2 24
$86.3M
$8.1M
Q1 24
$79.2M
$8.5M
Stockholders' Equity
NN
NN
RKDA
RKDA
Q4 25
$-86.2M
$4.1M
Q3 25
$-22.1M
$5.4M
Q2 25
$-47.2M
$4.5M
Q1 25
$6.6M
$8.9M
Q4 24
$50.1M
$6.2M
Q3 24
$65.6M
$10.3M
Q2 24
$63.8M
$11.7M
Q1 24
$55.9M
$10.6M
Total Assets
NN
NN
RKDA
RKDA
Q4 25
$247.0M
$6.5M
Q3 25
$263.1M
$8.6M
Q2 25
$256.7M
$7.8M
Q1 25
$268.6M
$13.0M
Q4 24
$161.7M
$13.5M
Q3 24
$171.7M
$15.2M
Q2 24
$172.3M
$17.4M
Q1 24
$165.6M
$16.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NN
NN
RKDA
RKDA
Operating Cash FlowLast quarter
$-16.1M
$-861.0K
Free Cash FlowOCF − Capex
$-16.1M
FCF MarginFCF / Revenue
-1702.9%
Capex IntensityCapex / Revenue
1.6%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-50.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NN
NN
RKDA
RKDA
Q4 25
$-16.1M
$-861.0K
Q3 25
$-9.0M
$-257.0K
Q2 25
$-13.5M
$-2.0M
Q1 25
$-12.2M
$-1.6M
Q4 24
$-11.9M
$-2.2M
Q3 24
$-6.8M
$-1.8M
Q2 24
$-12.3M
$-2.5M
Q1 24
$-7.0M
$-3.2M
Free Cash Flow
NN
NN
RKDA
RKDA
Q4 25
$-16.1M
Q3 25
$-9.0M
Q2 25
$-13.6M
Q1 25
$-12.2M
Q4 24
$-12.1M
Q3 24
$-6.8M
Q2 24
$-12.4M
$-2.5M
Q1 24
$-7.0M
$-3.2M
FCF Margin
NN
NN
RKDA
RKDA
Q4 25
-1702.9%
Q3 25
-1011.6%
Q2 25
-1127.4%
Q1 25
-793.3%
Q4 24
-634.0%
Q3 24
-422.0%
Q2 24
-1126.1%
-188.3%
Q1 24
-670.8%
-326.5%
Capex Intensity
NN
NN
RKDA
RKDA
Q4 25
1.6%
0.0%
Q3 25
0.9%
0.0%
Q2 25
2.2%
0.0%
Q1 25
1.9%
0.0%
Q4 24
8.8%
0.0%
Q3 24
0.1%
0.0%
Q2 24
13.5%
0.2%
Q1 24
3.1%
1.3%
Cash Conversion
NN
NN
RKDA
RKDA
Q4 25
Q3 25
-18.56×
-0.30×
Q2 25
Q1 25
-0.61×
Q4 24
Q3 24
Q2 24
-2.31×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons